{"id": "CMU_1:6", "en": "and are you having any of the following symptoms with your chest pain", "es": "y tiene alguno de los siguientes síntomas además de dolor de pecho", "questions": "[\"What symptoms are being asked about with chest pain?\", \"What are the following symptoms that may accompany chest pain?\"]", "answers": "[\"the following symptoms\", \"Chest pain\"]"}
{"id": "CMU_1:7", "en": "and are you having a runny nose?", "es": "¿y tiene secreción nasal?", "questions": "[\"What is a runny nose?\", \"Are you experiencing a runny nose?\", \"What symptoms are being asked about?\"]", "answers": "[\"A symptom where mucus flows out of the nose\"], [\"Are you experiencing a runny nose?\"], [\"A symptom\"]"}
{"id": "CMU_1:11", "en": "and does this pain move from your chest?", "es": "¿y este dolor sale de su pecho?", "questions": "[\"Does the pain move from your chest?\", \"Is there pain mentioned elsewhere besides the chest?\"]", "answers": "[\"Yes\", \"Yes\"]"}
{"id": "CMU_1:12", "en": "and drink lots of fluids", "es": "y beba mucho líquido", "questions": "[\"How should one stay hydrated?\", \"What is recommended to drink lots of fluids for?\"]", "answers": "[\"Stay hydrated\", \"Staying hydrated\"]"}
{"id": "CMU_1:21", "en": "and she is sorta have the same symptoms", "es": "y digamos que ella tiene los mismos síntomas", "questions": "[\"What symptoms does she have?\", \"How are her symptoms described?\"]", "answers": "[\"the same symptoms\", \"sorta\"]"}
{"id": "CMU_1:22", "en": "and tell me what symptoms are you having now?", "es": "¿y dígame qué síntomas tiene ahora?", "questions": "[\"What symptoms am I currently experiencing?\", \"What symptoms do I have now?\"]", "answers": "[\"What symptoms am I currently experiencing?\", \"What symptoms do I have now?\"]"}
{"id": "CMU_1:28", "en": "and your symptoms do not go away in five days", "es": "y los síntomas no desaparecen en cinco días", "questions": "[\"How long do your symptoms typically last?\", \"What happens if your symptoms do not go away after five days?\"]", "answers": "[\"five days\", \"do not go away\"]"}
{"id": "CMU_1:32", "en": "any sharp pain on your left side of your chest?", "es": "¿algún dolor agudo en el lado izquierdo del pecho?", "questions": "[\"What type of pain is being referred to?\", \"On which side of your chest does the pain occur?\", \"Where exactly on your chest do you feel the sharp pain?\", \"What could be causing sharp pain on your left side of your chest?\"]", "answers": "[\"Sharp pain\"], [\"Left side\"], [\"Your left side\"], [\"Heart attack, pneumothorax, or musculoskeletal injury\"]"}
{"id": "CMU_1:34", "en": "are you having any difficulty breathing now", "es": "ahora tiene algo de dificultad para respirar", "questions": "[\"Are you currently experiencing difficulty breathing?\", \"Is there any difficulty breathing now?\", \"Do you have difficulty breathing at the moment?\", \"Are you having trouble breathing right now?\", \"Is breathing difficult for you now?\"]", "answers": "[\"Are you currently experiencing difficulty breathing?\", \"Is there any difficulty breathing now?\", \"Do you have difficulty breathing at the moment?\", \"Are you having trouble breathing right now?\", \"Is breathing difficult for you now?\"]"}
{"id": "CMU_1:39", "en": "besides the diabetes do you have other problems or important diseases?", "es": "además de la diabetes, ¿tiene otros problemas o enfermedades importantes?", "questions": "[\"What other problems or important diseases do I have besides diabetes?\"]", "answers": "[\"other problems or important diseases\"]"}
{"id": "CMU_1:42", "en": "but if you have the cough", "es": "pero si tiene tos", "questions": "[\"What is the condition if you have the cough?\"]", "answers": "[\"the cough\"]"}
{"id": "CMU_1:48", "en": "cause they're having a cough", "es": "porque tienen tos", "questions": "[\"Why are they having a cough?\", \"What is causing their cough?\"]", "answers": "[\"cause\", \"a cough\"]"}
{"id": "CMU_1:52", "en": "do you have any blood pressure problem as far as you know?", "es": "¿tiene algún problema de presión arterial hasta donde sabe?", "questions": "[\"Do I have any blood pressure problems?\", \"What kind of problems with blood pressure are you aware of?\"]", "answers": "[\"Do I have any blood pressure problems?\", \"What kind of problems with blood pressure are you aware of?\"]"}
{"id": "CMU_1:59", "en": "do your relatives have the same symptoms", "es": "sus familiares tienen los mismos síntomas", "questions": "[\"Who are your relatives?\", \"Do your relatives have the same symptoms as you?\", \"What symptoms do you have?\"]", "answers": "[\"Your relatives\", \"Do your relatives have the same symptoms as you?\", \"The symptoms\"]"}
{"id": "CMU_1:62", "en": "have a dry cough a cold and runny nose vomiting diarrhea", "es": "tener tos seca resfriado y secreción nasal vómitos diarrea", "questions": "[\"What symptoms are mentioned?\", \"What does 'dry cough' indicate?\", \"What other symptoms are present besides a cold and runny nose?\", \"What gastrointestinal symptoms are mentioned?\"]", "answers": "[\"A dry cough, a cold, runny nose, vomiting, and diarrhea\"], [\"Indicates a lack of mucus in the cough\"], [\"Vomiting and diarrhea\"], [\"Vomiting and diarrhea\"])"}
{"id": "CMU_1:67", "en": "i don't think i have high blood pressure", "es": "no creo tener presión arterial alta", "questions": "[\"Do you think you have high blood pressure?\", \"What do you believe about your blood pressure status?\"]", "answers": "[\"Yes\", \"I believe\"]"}
{"id": "CMU_1:68", "en": "i feel a pain in the chest here in the front part of the chest", "es": "siento dolor de pecho aquí, en la parte de adelante del pecho", "questions": "[\"Where do you feel the pain?\", \"What part of your chest do you feel the pain in?\", \"What type of pain do you feel in your chest?\"]", "answers": "[\"the front part of the chest\", \"front part of the chest\", \"a pain\"]"}
{"id": "CMU_1:75", "en": "i had a short sharp pain in my chest", "es": "tuve un dolor agudo breve en el pecho", "questions": "[\"What kind of pain did you have in your chest?\", \"How long did the pain last?\", \"Was the pain sharp?\", \"Where exactly was the pain located in your chest?\"]", "answers": "[\"A short sharp pain\", \"Not specified\", \"Yes\", \"In your chest\"]"}
{"id": "CMU_1:77", "en": "i have hay fever though too", "es": "aunque también tengo alergia al polen", "questions": "[\"What do you have besides hay fever?\", \"How many types of allergies do you have?\", \"What is your condition besides hay fever?\"]", "answers": "[\"Hay fever\", \"2\", \"Condition\"]"}
{"id": "CMU_1:78", "en": "i have made on the body around the chest area?", "es": "{NS}", "questions": "[\"Where have you made on your body around the chest area?\"]", "answers": "[\"the body\"]"}
{"id": "CMU_1:85", "en": "i see it going from the center of your chest going up to your neck", "es": "veo que sube desde el centro de su pecho hasta su cuello", "questions": "[\"Where does the issue start in your body?\", \"Does the issue travel upwards from the center of your chest to your neck?\", \"What is starting at the center of your chest and moving towards your neck?\"]", "answers": "[\"the center of your chest\", \"yes\", \"the issue\"]"}
{"id": "CMU_1:88", "en": "it hurts in the chest", "es": "me duele el pecho", "questions": "[\"What part of the body hurts?\"]", "answers": "[\"the chest\"]"}
{"id": "CMU_1:94", "en": "it is occurring right in the middle of my chest", "es": "está ocurriendo justo en el centro de mi pecho", "questions": "[\"Where is it occurring?\", \"What is occurring?\", \"In which part of the body is it occurring?\"]", "answers": "[\"my chest\", \"it\", \"the middle of the body\"]"}
{"id": "CMU_1:95", "en": "it is right in the center of my chest", "es": "es justo en el centro de mi pecho", "questions": "[\"Where is it located in your body?\", \"What part of your body is mentioned?\"]", "answers": "[\"Your chest\", \"Chest\"]"}
{"id": "CMU_1:96", "en": "it sounds like you just may have the garden variety cold or a flu", "es": "suena como que quizás solo tenga un resfriado común y corriente o una gripe", "questions": "[\"What does 'garden variety' mean in this context?\", \"What could be the illness being referred to?\"]", "answers": "[\"Common\", \"Cold or flu\"]"}
{"id": "CMU_1:100", "en": "i will send you an image", "es": "le enviaré una imagen", "questions": "[\"What will you send me?\", \"What kind of file do you intend to send?\"]", "answers": "[\"an image\", \"a file\"]"}
{"id": "CMU_1:101", "en": "i will send you an image on your screen", "es": "le enviaré una imagen en su pantalla", "questions": "[\"What will you send me?\", \"On what device will the image be displayed?\", \"Why are you sending the image to my screen?\"]", "answers": "[\"An image\", \"Your screen\", \"To display the image\"]"}
{"id": "CMU_1:104", "en": "most of the time it is this type of chest pain", "es": "casi siempre es este tipo de dolor de pecho", "questions": "[\"What type of chest pain is mentioned most of the time?\", \"What causes this type of chest pain most of the time?\"]", "answers": "[\"this type of chest pain\", \"this type of chest pain\"]"}
{"id": "CMU_1:105", "en": "my sister has similar symptoms", "es": "mi hermana tiene síntomas similares", "questions": "[\"What symptoms does your sister have?\", \"What symptoms are similar to your sister's symptoms?\"]", "answers": "[\"similar symptoms\", \"similar symptoms\"]"}
{"id": "CMU_1:107", "en": "now i send you an image", "es": "ahora le envío una imagen", "questions": "[\"What do you need me to do with the image?\", \"What action are you requesting regarding the image?\"]", "answers": "[\"send you\", \"send\"]"}
{"id": "CMU_1:112", "en": "or if you have high blood pressure", "es": "o si tiene presión arterial alta", "questions": "[\"What condition does 'or if you have high blood pressure' refer to?\"]", "answers": "[\"high blood pressure\"]"}
{"id": "CMU_1:119", "en": "so your chest pain started this morning", "es": "así que el dolor de pecho comenzó esta mañana", "questions": "[\"When did your chest pain start?\", \"What time this morning did your chest pain start?\", \"What kind of pain did you experience this morning?\", \"When did you first notice your chest pain this morning?\"]", "answers": "[\"This morning\", \"This morning\", \"Chest\", \"This morning\"]"}
{"id": "CMU_1:125", "en": "the fever started two days ago", "es": "la fiebre empezó hace dos días", "questions": "[\"When did the fever start?\", \"How long has the fever been going on for?\"]", "answers": "[\"two days ago\", \"two days\"]"}
{"id": "CMU_1:126", "en": "the muscle pains with the hay fever", "es": "los dolores musculares con la alergia al polen", "questions": "[\"What are the symptoms mentioned in the sentence?\", \"What condition is associated with hay fever according to the sentence?\", \"What type of pain is mentioned in relation to hay fever?\"]", "answers": "[\"Muscle pains and hay fever\", \"Hay fever\", \"Muscle pains\"]"}
{"id": "CMU_1:129", "en": "well from my point of view it is a little flu", "es": "bueno, desde mi punto de vista, es un poco de gripe", "questions": "[\"What does the speaker consider this to be?\", \"How does the speaker compare it to a flu?\"]", "answers": "[\"a little flu\", \"little\"]"}
{"id": "CMU_1:132", "en": "well madam from listening to your symptoms it sounds like you've got one of the flu viruses", "es": "bueno, señora, al escuchar sus síntomas, parece que tiene uno de los virus de la gripe", "questions": "[\"What does it sound like I have based on my symptoms?\", \"Which flu virus do I seem to have based on my symptoms?\", \"What symptoms am I experiencing that make it sound like I have a flu virus?\"]", "answers": "[\"one of the flu viruses\", \"a flu virus\", \"your symptoms\"]"}
{"id": "CMU_1:138", "en": "you are probably having chest pain", "es": "probablemente tenga dolor de pecho", "questions": "[\"What type of pain are you experiencing?\", \"Where are you feeling the pain?\", \"Is the pain new or has it been ongoing?\", \"What might be causing the chest pain?\", \"How severe is the chest pain?\"]", "answers": "[\"Chest pain\", \"In the chest\", \"New\", \"Not specified\", \"Not specified\"]"}
{"id": "PubMed_9:791", "en": "Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020", "es": "Estimaciones preliminares de la prevalencia de afecciones médicas subyacentes seleccionadas entre pacientes con enfermedad por coronavirus 2019 — Estados Unidos, 12 de febrero–28 de marzo de 2020", "questions": "[\"What are the preliminary estimates of?\", \"Which underlying health conditions are being studied?\", \"For which disease are the prevalence estimates being calculated?\", \"When were the data collection dates for this study?\"]", "answers": "[\"Prevalence of selected underlying health conditions\", \"Selected underlying health conditions\", \"Coronavirus Disease 2019\", \"February 12–March 28, 2020\"]"}
{"id": "PubMed_9:792", "en": "On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.", "es": "El 11 de marzo de 2020, la Organización Mundial de la Salud declaró a la enfermedad por coronavirus 2019 (COVID-19) una pandemia.", "questions": "[\"When did the World Health Organization declare COVID-19 a pandemic?\", \"What disease was declared a pandemic by the World Health Organization on March 11, 2020?\"]", "answers": "[\"March 11, 2020\", \"Coronavirus Disease 2019 (COVID-19)\"]"}
{"id": "PubMed_9:793", "en": "As of March 28, 2020, a total of 571,678 confirmed COVID-19 cases and 26,494 deaths have been reported worldwide.", "es": "Al 28 de marzo de 2020, se ha registrado un total de 571 678 casos confirmados de COVID-19 y 26 494 muertes en todo el mundo.", "questions": "[\"What date is being referred to as the cutoff for the statistics?\", \"How many confirmed COVID-19 cases have been reported worldwide as of March 28, 2020?\", \"How many deaths have been reported worldwide due to COVID-19 as of March 28, 2020?\", \"What does the statistic include (cases or deaths)?\"]", "answers": "[\"March 28, 2020\", \"571,678\", \"26,494\", \"Both cases and deaths\"]"}
{"id": "PubMed_9:794", "en": "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.", "es": "Informes de China e Italia sugieren que los factores de riesgo de enfermedad grave incluyen la edad avanzada y la presencia de al menos una de varias afecciones médicas subyacentes.", "questions": "[\"What risk factors are suggested for severe disease?\", \"What does the presence of underlying health conditions imply?\", \"What two regions' reports are mentioned?\", \"What health conditions are referred to as potential risks?\"]", "answers": "[\"older age and the presence of at least one of several underlying health conditions\"], [\"underlying health conditions imply increased susceptibility to severe disease\"], [\"China and Italy\"], [\"several underlying health conditions\"]"}
{"id": "PubMed_9:795", "en": "U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "es": "Los adultos mayores de EE. UU., incluidos los de ≥65 años y en particular aquellos de ≥85 años, también parecen tener un mayor riesgo de complicaciones graves asociadas a la COVID-19; sin embargo, aún no se han informado datos que describan las afecciones médicas subyacentes entre los pacientes con COVID-19 en EE. UU.", "questions": "[\"What appears to be at higher risk for severe COVID-19–associated outcomes?\", \"Which age groups are considered at higher risk for severe COVID-19–associated outcomes?\", \"What age group is described as being particularly at higher risk?\", \"What is unique about U.S. older adults?\", \"What kind of data has not yet been reported regarding U.S. COVID-19 patients?\"]", "answers": "[\"U.S. older adults\", \"those aged ≥65 years and particularly those aged ≥85 years\", \"those aged ≥85 years\", \"underlying health conditions\", \"underlying health conditions\"]"}
{"id": "PubMed_9:796", "en": "As of March 28, 2020, U.S. states and territories have reported 122,653 U.S. COVID-19 cases to CDC, including 7,162 (5.8%) for whom data on underlying health conditions and other known risk factors for severe outcomes from respiratory infections were reported.", "es": "Al 28 de marzo de 2020, los estados y territorios de EE. UU. han informado 122 653 casos de COVID-19 en EE. UU. a los CDC, incluidos 7162 (5,8 %) sobre quienes se informaron datos de afecciones médicas subyacentes y otros factores de riesgo conocidos de complicaciones graves de infecciones respiratorias.", "questions": "[\"When was the information reported?\", \"How many U.S. COVID-19 cases have been reported by U.S. states and territories as of March 28, 2020?\", \"What percentage of reported cases had data on underlying health conditions and other known risk factors?\", \"What does 'underlying health conditions' refer to in this context?\", \"What does 'severe outcomes from respiratory infections' refer to in this context?\"]", "answers": "[\"March 28, 2020\", \"122,653\", \"5.8%\", \"'underlying health conditions' refers to pre-existing medical conditions that may increase susceptibility to severe outcomes from respiratory infections.\", \"'severe outcomes from respiratory infections' refers to complications or deaths resulting from respiratory infections.\"]"}
{"id": "PubMed_9:797", "en": "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "es": "Entre estos 7162 casos, 2692 (37,6 %) pacientes tenían una o más afecciones médicas subyacentes o factores de riesgo, y 4470 (62,4 %) no tenían ninguna de estas afecciones informadas.", "questions": "[\"What percentage of cases had one or more underlying health condition or risk factor?\", \"How many cases had none of these conditions reported?\", \"What does the term 'underlying health condition or risk factor' refer to?\"]", "answers": "[\"37.6%\", \"4470\", \"'underlying health condition or risk factor'\"]"}
{"id": "PubMed_9:798", "en": "The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%).", "es": "El porcentaje de pacientes con COVID-19 que tenían al menos una afección médica subyacente o factor de riesgo era más alto entre quienes requerían internación en la unidad de cuidados intensivos (UCI) (358 de 457, 78 %) y quienes requerían hospitalización sin internación en la UCI (732 de 1037, 71 %) que entre quienes no eran hospitalizados (1388 de 5143, 27 %).", "questions": "[\"What percentage of COVID-19 patients required ICU admission?\", \"What percentage required hospitalization without ICU admission?\", \"What percentage were not hospitalized?\", \"What does the sentence compare regarding hospitalization rates?\", \"What conditions or risk factors are being considered?\"]", "answers": "[\"78%\", \"71%\", \"27%\", \"ICU admission vs. hospitalization without ICU admission\", \"underlying health conditions or risk factors\"]"}
{"id": "PubMed_9:799", "en": "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "es": "Las afecciones más informadas eran diabetes mellitus, enfermedad pulmonar crónica y enfermedad cardiovascular.", "questions": "[\"What are the most commonly reported conditions?\", \"What medical conditions were reported most frequently?\", \"Which three conditions were commonly reported?\", \"What diseases were found to be commonly reported?\"]", "answers": "[\"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"Diabetes mellitus, chronic lung disease, and cardiovascular disease\"]"}
{"id": "PubMed_9:800", "en": "These preliminary findings suggest that in the United States, persons with underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections appear to be at a higher risk for severe disease from COVID-19 than are persons without these conditions.", "es": "Estas conclusiones preliminares sugieren que, en Estados Unidos, las personas con afecciones médicas subyacentes u otros factores de riesgo reconocidos de complicaciones graves de infecciones respiratorias parecen tener un mayor riesgo de enfermedad grave por la COVID-19 que las personas que no presentan esas afecciones.", "questions": "[\"What do these preliminary findings suggest about the risk of severe disease from COVID-19?\", \"What conditions or risk factors are mentioned as potentially increasing the risk of severe disease?\", \"Where are these findings preliminary for assessing the risk of severe disease from COVID-19?\"]", "answers": "[\"Persons with underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections appear to be at a higher risk for severe disease from COVID-19 than are persons without these conditions.\", \"Underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections\", \"In the United States\"]"}
{"id": "PubMed_9:801", "en": "Data from laboratory-confirmed COVID-19 cases reported to CDC from 50 states, four U.S. territories and affiliated islands, the District of Columbia, and New York City with February 12–March 28, 2020 onset dates were analyzed.", "es": "Se analizaron los datos de casos de COVID-19 confirmados por laboratorio informados a los CDC de 50 estados, cuatro territorios estadounidenses e islas asociadas, el Distrito de Columbia y la ciudad de Nueva York, con fechas de aparición entre el 12 de febrero y el 28 de marzo de 2020.", "questions": "[\"What data was analyzed?\", \"When did the cases have onset dates?\", \"Which locations provided the data to CDC?\"]", "answers": "[\"Laboratory-confirmed COVID-19 cases\"], [\"February 12–March 28, 2020\"], [\"50 states, four U.S. territories and affiliated islands, the District of Columbia, and New York City\"]"}
{"id": "PubMed_9:802", "en": "Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.", "es": "Se excluyeron los casos de personas repatriadas a Estados Unidos desde Wuhan, China, y del crucero Diamond Princess.", "questions": "[\"What cases were excluded?\", \"From which locations were the cases excluded?\", \"What does 'repatriated' mean in this context?\"]", "answers": "[\"Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship\"], [\"Wuhan, China and the Diamond Princess cruise ship\"], [\"Returned\"]"}
{"id": "PubMed_9:803", "en": "For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.", "es": "Para los casos en los que se desconocía la fecha de aparición, se calculó la fecha de aparición restando 4 días (intervalo medio desde la aparición de los síntomas hasta fecha de toma de la muestra en casos con fechas conocidas en estos datos) a la primera toma de muestra.", "questions": "[\"What is used to estimate the date of onset for cases with missing onset dates?\", \"How is the date of onset estimated?\", \"What is subtracted from the earliest specimen collection date to estimate the date of onset?\", \"What information is used to calculate the median interval?\", \"What variable is subtracted from the earliest specimen collection date?\"]", "answers": "[\"The earliest specimen collection date\"], [\"The date of onset is estimated\"], [\"4 days\"], [\"The median interval from symptom onset to specimen collection date\"], [\"4 days\"]"}
{"id": "PubMed_9:804", "en": "Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.", "es": "Los departamentos de salud pública informaron casos a los CDC usando un formulario de informe de casos estandarizado que captura información (sí, no o se desconoce) sobre las siguientes afecciones y posibles factores de riesgo: enfermedad pulmonar crónica (que incluye asma, enfermedad pulmonar obstructiva crónica [EPOC] y enfisema); diabetes mellitus; enfermedad cardiovascular; enfermedad renal crónica; enfermedad hepática crónica; condición de inmunocomprometido; trastorno neurológico, del desarrollo neurológico o discapacidad intelectual; embarazo; condición de fumador actual; antecedentes de tabaquismo u otra enfermedad crónica.", "questions": "[\"What conditions and potential risk factors are reported by public health departments to CDC?\", \"What type of form is used for reporting cases to CDC?\", \"What information does the standardized case report form capture?\", \"Which chronic diseases are mentioned in the sentence?\", \"Which health conditions are included under 'chronic lung disease'?\"]", "answers": "[\"chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema), diabetes mellitus, cardiovascular disease, chronic renal disease, chronic liver disease, immunocompromised condition, neurologic disorder, neurodevelopmental, or intellectual disability, pregnancy, current smoking status, former smoking status, or other chronic disease\", \"a standardized case report form\", \"yes, no, or unknown information\", \"chronic lung disease, chronic renal disease, chronic liver disease, immunocompromised condition, neurologic disorder, neurodevelopmental, or intellectual disability, pregnancy, current smoking status, former smoking status, or other chronic disease\", \"asthma, chronic obstructive pulmonary disease [COPD], and emphysema\"]"}
{"id": "PubMed_9:805", "en": "Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.", "es": "Los datos informados a los CDC son preliminares y pueden ser actualizados por los departamentos de salud con el tiempo; es posible que faltaran datos críticos al momento del informe inicial; por lo tanto, este análisis es descriptivo y no pudieron hacerse comparaciones estadísticas.", "questions": "[\"What are the preliminary nature and potential updates of the data reported to CDC?\", \"Which data elements might be missing from the initial report?\", \"Why is the analysis described as descriptive?\", \"Can statistical comparisons be made with this analysis?\"]", "answers": "[\"The data reported to CDC are preliminary and can be updated by health departments over time\", \"Critical data elements might be missing at the time of initial report\", \"No statistical comparisons could be made\", \"No\"]"}
{"id": "PubMed_9:806", "en": "The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.", "es": "Se calcularon los porcentajes de pacientes de todas las edades con afecciones médicas subyacentes que no fueron hospitalizados, fueron hospitalizados sin internación en la UCI y fueron hospitalizados con internación en la UCI.", "questions": "[\"What were calculated for patients with underlying health conditions?\", \"What categories of hospitalization were considered?\", \"What age groups are included in the study?\"]", "answers": "[\"Percentages\", \"Not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission\", \"All\"]"}
{"id": "PubMed_9:807", "en": "Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.", "es": "Se estimaron los porcentajes de hospitalizaciones con y sin internación en la UCI en personas de ≥19 años con y sin afecciones médicas subyacentes.", "questions": "[\"What percentages were estimated?\", \"For which age group was this estimation done?\", \"What conditions were considered when estimating hospitalizations?\", \"What does 'ICU admission' refer to?\", \"What two categories of hospitalizations were compared?\"]", "answers": "[\"Percentages\"], [\"≥19 years\"], [\"underlying health conditions\"], [\"Intensive Care Unit admission\"], [\"With and without ICU admission\"]"}
{"id": "PubMed_9:808", "en": "This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).", "es": "Esta parte del análisis se limitó a personas de ≥19 años debido al tamaño pequeño de la muestra de casos en niños con afecciones médicas subyacentes informadas (N = 32).", "questions": "[\"What age group was this part of the analysis limited to?\", \"Why was the analysis limited to persons aged ≥19 years?\", \"What information is provided about the sample size of cases in children?\", \"How many cases were there in children with reported underlying health conditions?\"]", "answers": "[\"Persons aged ≥19 years\"], [\"Because of the small sample size\"], [\"The sample size of cases in children was provided\"], [32]"}
{"id": "PubMed_9:809", "en": "To account for missing data among these preliminary reports, ranges were estimated with a lower bound including cases with both known and unknown status for hospitalization with and without ICU admission as the denominator and an upper bound using only cases with known outcome status as the denominator.", "es": "Para resolver la falta de datos entre estos informes preliminares, los rangos se estimaron con un límite inferior, que incluía como denominador los casos con estado conocido y desconocido de hospitalización con y sin internación en la UCI, y un límite superior, que solo incluía casos con estado de desenlace clínico conocido como denominador.", "questions": "[\"What type of data is accounted for?\", \"What is used as the denominator for the lower bound?\", \"What is used as the denominator for the upper bound?\", \"What two statuses determine the lower bound denominator?\", \"What is the purpose of estimating ranges?\", \"What are preliminary reports mentioned in the sentence?\"]", "answers": "[\"Missing data\", \"Cases with both known and unknown status for hospitalization with and without ICU admission\", \"Cases with known outcome status\", \"Hospitalization with and without ICU admission\", \"To account for missing data\", \"Preliminary reports\"]"}
{"id": "PubMed_9:810", "en": "Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.", "es": "Debido al tamaño pequeño de la muestra y a la falta de datos sobre afecciones médicas subyacentes entre los pacientes con COVID-19 que murieron, no se calcularon las tasas de letalidad para personas con y sin afecciones subyacentes.", "questions": "[\"What is the reason for not estimating case-fatality rates?\", \"What kind of data was missing?\", \"What does 'underlying health conditions' refer to in this context?\", \"What does 'case-fatality rates' mean here?\"]", "answers": "[\"Small sample size and missing data on underlying health conditions among COVID-19 patients who died\"], [\"Underlying health conditions\"], [\"Case-fatality rates\"], [\"The proportion of deaths among confirmed cases\"]"}
{"id": "PubMed_9:811", "en": "As of March 28, 2020, a total of 122,653 laboratory-confirmed COVID-19 cases (Figure) and 2,112 deaths were reported to CDC.", "es": "Al 28 de marzo de 2020, se informó a los CDC un total de 122 653 casos de COVID-19 confirmados por laboratorio (figura) y 2112 muertes.", "questions": "[\"When was the information provided as of?\", \"How many laboratory-confirmed COVID-19 cases were reported?\", \"How many deaths were reported?\", \"What does Figure refer to?\", \"What is the disease being referred to by the cases and deaths?\"]", "answers": "[\"March 28, 2020\", \"122,653\", \"2,112\", \"Figure\", \"COVID-19\"]"}
{"id": "PubMed_9:812", "en": "Case report forms were submitted to CDC for 74,439 (60.7%) cases.", "es": "Se enviaron a los CDC formularios de informe de casos de 74 439 (60,7 %) casos.", "questions": "[\"What percentage of cases were submitted to CDC?\", \"How many total cases were there?\", \"What is the form used for these submissions called?\"]", "answers": "[\"60.7%\", \"74439\", \"Case report forms\"]"}
{"id": "PubMed_9:813", "en": "Data on presence or absence of underlying health conditions and other recognized risk factors for severe outcomes from respiratory infections (i.e., smoking and pregnancy) were available for 7,162 (5.8%) patients (Table 1).", "es": "Estaban disponibles datos sobre la presencia o ausencia de afecciones médicas subyacentes y otros factores de riesgo reconocidos de complicaciones graves de infecciones respiratorias (es decir, tabaquismo y embarazo) de 7162 (5,8 %) pacientes (tabla 1).", "questions": "[\"What data was available for 7,162 patients?\", \"What are the two recognized risk factors for severe outcomes from respiratory infections mentioned?\", \"What does the phrase 'presence or absence' refer to?\", \"What percentage of patients had data available on underlying health conditions and risk factors?\"]", "answers": "[\"Underlying health conditions and other recognized risk factors\", \"Smoking and pregnancy\", \"Whether a patient has a condition or not\", \"5.8%\"]"}
{"id": "PubMed_9:814", "en": "Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.", "es": "Aproximadamente un tercio de esos pacientes (2692, 37,6 %) tenía al menos una afección subyacente o un factor de riesgo.", "questions": "[\"What percentage of patients had at least one underlying condition or risk factor?\", \"How many patients had at least one underlying condition or risk factor?\", \"What are the conditions or risk factors mentioned in the sentence?\"]", "answers": "[\"37.6%\", \"2692\", \"underlying condition or risk factor\"]"}
{"id": "PubMed_9:815", "en": "Diabetes mellitus (784, 10.9%), chronic lung disease (656, 9.2%), and cardiovascular disease (647, 9.0%) were the most frequently reported conditions among all cases.", "es": "Diabetes mellitus (784, 10,9 %), enfermedad pulmonar crónica (656, 9,2 %) y enfermedad cardiovascular (647, 9,0 %) eran las afecciones más informadas entre todos los casos.", "questions": "[\"What conditions were the most frequently reported among all cases?\", \"What percentage represents diabetes mellitus?\", \"What percentage represents chronic lung disease?\", \"What percentage represents cardiovascular disease?\"]", "answers": "[\"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"10.9%\", \"9.2%\", \"9.0%\"]"}
{"id": "PubMed_9:816", "en": "Among 457 ICU admissions and 1,037 non-ICU hospitalizations, 358 (78%) and 732 (71%), respectively occurred among persons with one or more reported underlying health condition.", "es": "Entre 457 internaciones en la UCI y 1037 hospitalizaciones sin internación en la UCI, 358 (78 %) y 732 (71 %), respectivamente, ocurrieron entre personas con una o más afecciones médicas subyacentes informadas.", "questions": "[\"What percentage of ICU admissions and non-ICU hospitalizations occurred among persons with underlying health conditions?\", \"How many ICU admissions and non-ICU hospitalizations were there in total?\", \"What is the number of ICU admissions?\", \"What is the number of non-ICU hospitalizations?\", \"What percentage of non-ICU hospitalizations occurred among persons with underlying health conditions?\"]", "answers": "[\"78%\", \"1494\", \"358\", \"1037\", \"71%\"]"}
{"id": "PubMed_9:817", "en": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.", "es": "En cambio, se informó que 1388 de 5143 (27 %) pacientes con COVID-19 que no fueron hospitalizados tenían al menos una afección médica subyacente.", "questions": "[\"What percentage of COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"How many COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition?\", \"What is the total number of COVID-19 patients studied?\", \"What is the ratio of patients with underlying health conditions among those who were not hospitalized?\"]", "answers": "[\"27%\", \"1388\", \"5143\", \"1388/3755\"])"}
{"id": "PubMed_9:818", "en": "Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).", "es": "Entre los pacientes ≥19 años, el porcentaje de hospitalizaciones sin internación en la UCI era mayor en aquellos con afecciones médicas subyacentes (27,3 %–29,8 %) que en aquellos sin afecciones médicas subyacentes (7,2 %–7,8 %); el porcentaje de casos que requirieron internación en la UCI también era mayor en aquellos con afecciones médicas subyacentes (13,3 %–14,5 %) que en aquellos que no tenían estas afecciones (2,2 %–2,4 %) (tabla 2).", "questions": "[\"What percentage of non-ICU hospitalizations was higher among patients with underlying health conditions?\", \"What percentage of non-ICU hospitalizations was higher among patients without underlying health conditions?\", \"What percentage of cases resulted in an ICU admission was higher for patients with underlying health conditions?\", \"What percentage of cases resulted in an ICU admission was higher for patients without underlying health conditions?\"]", "answers": "[\"27.3%–29.8%\", \"7.2%–7.8%\", \"13.3%–14.5%\", \"2.2%–2.4%\"]"}
{"id": "PubMed_9:819", "en": "Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).", "es": "Se informaron cantidades reducidas de pacientes con COVID-19 <19 años hospitalizados (48) o internados en una UCI (ocho).", "questions": "[\"How many COVID-19 patients aged < 19 years were reported to be hospitalized?\", \"How many COVID-19 patients aged < 19 years were admitted to an ICU?\", \"What age group was reported in the study?\", \"What outcomes were reported for patients aged < 19 years?\"]", "answers": "[\"48\", \"eight\", \"< 19 years\", \"hospitalized or admitted to an ICU\"]"}
{"id": "PubMed_9:820", "en": "In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.", "es": "En cambio, 335 pacientes <19 no fueron hospitalizados y faltaban datos sobre la hospitalización de 1342.", "questions": "[\"What age group was not hospitalized?\", \"How many patients aged < 19 were not hospitalized?\", \"How many patients had missing data on hospitalization?\", \"What is the relationship between hospitalization status and age group < 19?\"]", "answers": "[\"patients aged &lt; 19 years\"], [\"335\"], [\"1,342\"], [\"not hospitalized\"]"}
{"id": "PubMed_9:821", "en": "Among all COVID-19 patients with complete information on underlying conditions or risk factors, 184 deaths occurred (all among patients aged ≥19 years); 173 deaths (94%) were reported among patients with at least one underlying condition.", "es": "Entre todos los pacientes con COVID-19 sobre los que había información completa de afecciones subyacentes o factores de riesgo, se produjeron 184 muertes (todas entre pacientes ≥19 años); se informaron 173 muertes (94 %) entre los pacientes con al menos una afección subyacente.", "questions": "[\"What is the total number of deaths among COVID-19 patients with complete information on underlying conditions or risk factors?\", \"What percentage of deaths among patients with at least one underlying condition?\", \"What age group had no reported deaths?\", \"How many deaths were reported among patients with at least one underlying condition?\"]", "answers": "[\"184 deaths\", \"94%\", \"≥19 years\", \"173 deaths\"]"}
{"id": "PubMed_9:822", "en": "Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.", "es": "Entre los 122 653 casos de COVID-19 en EE. UU. informados a los CDC hasta el 28 de marzo de 2020, había datos disponibles sobre afecciones médicas subyacentes o posibles factores de riesgo de 7162 (5,8 %) pacientes; entre estos pacientes, mayores porcentajes de pacientes con afecciones subyacentes fueron hospitalizados e internados en la UCI que de pacientes sin afecciones subyacentes informadas.", "questions": "[\"What percentage of U.S. COVID-19 cases had data available pertaining to underlying health conditions or potential risk factors?\", \"What does the sentence compare regarding patients with and without reported underlying conditions?\", \"What is the difference in admission rates between patients with and without underlying conditions?\", \"What is the difference in ICU admission rates between patients with and without underlying conditions?\"]", "answers": "[\"5.8%\", \"admission to the hospital and to an ICU\", \"not specified\", \"not specified\"]"}
{"id": "PubMed_9:823", "en": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.", "es": "Estos resultados son coincidentes con los datos de China e Italia, que sugieren que los pacientes con afecciones médicas subyacentes y factores de riesgo, incluidos, entre otros, diabetes mellitus, hipertensión, EPOC, enfermedad de las arterias coronarias, enfermedad cerebrovascular, enfermedad renal crónica y tabaquismo, podrían tener un mayor riesgo de enfermarse gravemente o morir a causa de la COVID-19.", "questions": "[\"What results are consistent with findings from China and Italy?\", \"What conditions and risk factors are mentioned as potentially increasing the risk for severe disease or death from COVID-19?\", \"What diseases are listed as potential risk factors for severe disease or death from COVID-19?\", \"What diseases are mentioned as being associated with higher risk for severe disease or death from COVID-19?\"]", "answers": "[\"Results indicating higher risk for severe disease or death from COVID-19\"], [\"diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking\"], [\"diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease\"], [\"diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking\"]"}
{"id": "PubMed_9:824", "en": "This analysis was limited by small numbers and missing data because of the burden placed on reporting health departments with rapidly rising case counts, and these findings might change as additional data become available.", "es": "Este análisis estuvo limitado por las cantidades reducidas y la falta de datos debido a la carga que recae sobre los departamentos de salud encargados de informar casos ante el rápido aumento de los conteos de casos, y estos resultados podrían variar a medida que estén disponibles más datos.", "questions": "[\"What was the limitation of the analysis?\", \"Why were small numbers and missing data a problem?\", \"What caused the burden on reporting health departments?\", \"What could change based on additional data?\", \"What type of information was limited by small numbers and missing data?\"]", "answers": "[\"Small numbers and missing data\", \"The burden placed on reporting health departments with rapidly rising case counts\", \"Rapidly rising case counts\", \"These findings\", \"Health department reporting\"]"}
{"id": "PubMed_9:825", "en": "It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.", "es": "Aún se desconoce si la gravedad o el nivel de control de las afecciones médicas subyacentes afectan el riesgo de enfermedad grave asociada a la COVID-19.", "questions": "[\"What is not yet known?\", \"What might affect the risk for severe disease associated with COVID-19?\", \"What is associated with severe disease?\", \"What conditions are mentioned in the sentence?\", \"What is the disease mentioned in the sentence?\"]", "answers": "[\"whether the severity or level of control of underlying health conditions\", \"the severity or level of control of underlying health conditions\", \"severe disease\", \"underlying health conditions\", \"COVID-19\"]"}
{"id": "PubMed_9:826", "en": "Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.", "es": "Muchas de estas afecciones médicas subyacentes son comunes en Estados Unidos: de acuerdo con datos autoinformados de 2018, la prevalencia de diabetes diagnosticada entre adultos estadounidenses fue del 10,1 %, y la prevalencia ajustada por edad de todos los tipos de enfermedad cardíaca en EE. UU. (salvo hipertensión sin otra afección cardíaca) fue del 10,6 % en 2017.", "questions": "[\"What underlying health conditions are common in the United States according to the sentence?\", \"What is the prevalence of diagnosed diabetes among U.S. adults based on self-reported 2018 data?\", \"What is the U.S. age-adjusted prevalence of all types of heart disease excluding hypertension without other heart disease based on 2017 data?\", \"What does the sentence compare regarding heart disease and diabetes?\" ]", "answers": "[\"diagnosed diabetes and all types of heart disease excluding hypertension without other heart disease\"], [\"10.1%\"], [\"10.6%\"], [\"heart disease and diabetes\"]]"}
{"id": "PubMed_9:827", "en": "The age-adjusted prevalence of COPD among U.S. adults is 5.9%, and in 2018, the U.S. estimated prevalence of current asthma among persons of all ages was 7.9%.", "es": "La prevalencia ajustada por edad de EPOC entre adultos estadounidenses es del 5,9 %, y en 2018, la prevalencia estimada en EE. UU. de asma crónica entre personas de todas las edades fue del 7,9 %.", "questions": "[\"What is the age-adjusted prevalence of COPD among U.S. adults?\", \"What was the estimated prevalence of current asthma among persons of all ages in 2018?\", \"How is the prevalence of COPD calculated?\", \"What does 'current asthma' refer to in this context?\", \"What does 'age-adjusted' mean in this statement?\"]", "answers": "[\"5.9%\", \"7.9%\", \"calculated\", \"current year's asthma\", \"adjusted for age\"]"}
{"id": "PubMed_9:828", "en": "CDC continues to develop and update resources for persons with underlying health conditions to reduce the risk of acquiring COVID-19.", "es": "Los CDC continúan desarrollando y actualizando recursos destinados a personas con afecciones médicas subyacentes para reducir el riesgo de contraer la COVID-19.", "questions": "[\"What does CDC continue to do regarding resources?\", \"For whom are these resources developed?\", \"What is the purpose of these resources?\", \"What can these resources help reduce?\", \"What condition is this resource aimed at reducing risk for?\"]", "answers": "[\"Develop and update resources\"], [\"Persons with underlying health conditions\"], [\"Reduce the risk of acquiring COVID-19\"], [\"Acquiring COVID-19\"], [\"Underlying health conditions\"]"}
{"id": "PubMed_9:829", "en": "The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.", "es": "La mayor prevalencia estimada de estas condiciones entre aquellos que integran este grupo inicial de pacientes con COVID-19 en EE. UU. y el riesgo potencialmente más alto de enfermarse más gravemente a causa de la COVID-19 debido a la presencia de afecciones subyacentes ponen de relieve la importancia de la prevención de la COVID-19 en personas con afecciones subyacentes.", "questions": "[\"What conditions are mentioned in the sentence?\", \"What does the sentence suggest about the risk for more severe disease?\", \"What is highlighted as important in the sentence?\", \"What group is being referred to as 'early group of U.S. COVID-19 patients'?\" ]", "answers": "[\"underlying conditions\", \"higher risk for more severe disease\", \"COVID-19 prevention\", \"U.S. COVID-19 patients\"]"}
{"id": "PubMed_9:830", "en": "The findings in this report are subject to at least six limitations.", "es": "Los resultados de este informe están sujetos a al menos seis limitaciones.", "questions": "[\"How many limitations does the report have?\", \"What are the limitations mentioned in the report?\"]", "answers": "[\"Six\", \"Subject to at least six limitations\"]"}
{"id": "PubMed_9:831", "en": "First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.", "es": "En primer lugar, estos datos son preliminares y el análisis estuvo limitado por la falta de datos debida a la carga de informes que recae sobre el departamento de salud ante el rápido aumento de los conteos de casos y los retrasos en el suministro de información que requiere revisión del expediente médico; estos resultados podrían variar a medida que estén disponibles más datos.", "questions": "[\"What are preliminary?\", \"What type of analysis was limited?\", \"What health department reporting burden is mentioned?\", \"What is required for medical chart review?\", \"Why were delays in completing information mentioned?\", \"What might change as additional data become available?\"]", "answers": "[\"These data\"], [\"the analysis\"], [\"the health department reporting burden\"], [\"medical chart review\"], [\"delays in completion of information\"], [\"these findings\"]"}
{"id": "PubMed_9:832", "en": "Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.", "es": "La información sobre las afecciones subyacentes solo estaba disponible para 7162 (5,8 %) de los 122 653 casos informados a los CDC.", "questions": "[\"What information is limited in the sentence?\", \"What percentage of cases had information on underlying conditions?\", \"How many cases were reported to CDC in total?\", \"What does the number 7,162 represent?\"]", "answers": "[\"Underlying conditions\"], [\"5.8%\"], [\"122,653\"], [\"Cases with information on underlying conditions\"]"}
{"id": "PubMed_9:833", "en": "It cannot be assumed that those with missing information are similar to those with data on either hospitalizations or underlying health conditions.", "es": "No se puede dar por supuesto que aquellos respecto de quienes falta información son similares a aquellos de quienes se tienen datos sobre hospitalizaciones o afecciones médicas subyacentes.", "questions": "[\"What cannot be assumed?\", \"What type of information is missing?\", \"What two groups are being compared?\", \"What variables are considered when comparing the groups?\"]", "answers": "[\"That those with missing information\"], [\"Information\"], [\"Those with missing information and those with data on either hospitalizations or underlying health conditions\"], [\"Hospitalizations and underlying health conditions\"]"}
{"id": "PubMed_9:834", "en": "Second, these data are subject to bias in outcome ascertainment because of short follow-up time.", "es": "En segundo lugar, estos datos están sujetos a sesgo en la comprobación del desenlace clínico debido al breve tiempo de seguimiento.", "questions": "[\"What is subject to bias in outcome ascertainment?\", \"Why are the data subject to bias?\", \"What causes the bias in outcome ascertainment?\", \"What type of data are being referred to?\", \"How long is the follow-up time mentioned?\"]", "answers": "[\"These data\", \"because of short follow-up time\", \"short follow-up time\", \"the data\", \"short\"]"}
{"id": "PubMed_9:835", "en": "Some outcomes might be underestimated, and long-term outcomes cannot be assessed in this analysis.", "es": "Algunos resultados podrían estar subestimados, y no es posible evaluar el desenlace clínico a largo plazo en este análisis.", "questions": "[\"What outcomes might be underestimated?\", \"What type of outcomes are mentioned?\", \"Can long-term outcomes be assessed in this analysis?\", \"What does the analysis focus on?\" ]", "answers": "[\"Some outcomes\", \"Short-term outcomes\", \"No\", \"Long-term outcomes\"]"}
{"id": "PubMed_9:836", "en": "Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.", "es": "En tercer lugar, debido a la disponibilidad reducida de pruebas en muchas jurisdicciones durante este período, este análisis probablemente esté sesgado hacia los casos más graves, y los resultados podrían variar a medida que las pruebas se generalicen.", "questions": "[\"What is the first reason mentioned for the bias in the analysis?\", \"Why is the analysis likely biased toward more severe cases?\", \"What could change as testing becomes more widespread?\", \"What does the sentence suggest about the reliability of the findings if testing becomes more widespread?\"]", "answers": "[\"Because of the limited availability of testing in many jurisdictions during this period\", \"This analysis is likely biased toward more severe cases\", \"Findings\", \"The reliability of the findings\"]"}
{"id": "PubMed_9:837", "en": "Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.", "es": "En cuarto lugar, debido a la naturaleza descriptiva de estos datos, no pudieron compararse las tasas de incidencia entre personas con y sin afecciones médicas subyacentes y, por ende, no fue posible estimar la diferencia en el riesgo de enfermedad grave a causa de la COVID-19 entre estos grupos.", "questions": "[\"What is the descriptive nature of the data referring to?\", \"What cannot be compared due to the descriptive nature of the data?\", \"What groups' risk difference of severe disease with COVID-19 could not be estimated?\"]", "answers": "[\"attack rates\", \"attack rates among persons with and without underlying health conditions\", \"persons with and without underlying health conditions\"]"}
{"id": "PubMed_9:838", "en": "Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.", "es": "En quinto lugar, no fue posible arribar a conclusiones acerca de las afecciones subyacentes que no se incluyeron en el formulario de informe de casos o acerca de distintas afecciones que se informaron en una única categoría abierta.", "questions": "[\"What underlying conditions were not included in the case report form?\", \"What different conditions were reported in a single category?\", \"What did no conclusions imply about the conditions not included in the case report form?\", \"What did no conclusions imply about the conditions reported in a single category?\"]", "answers": "[\"underlying conditions that were not included in the case report form\", \"different conditions that were reported in a single, umbrella category\", \"that underlying conditions were not included\", \"that different conditions were reported in a single category\"]"}
{"id": "PubMed_9:839", "en": "For example, asthma and COPD were included in a chronic lung disease category.", "es": "Por ejemplo, asma y EPOC se incluyeron en la categoría de enfermedad pulmonar crónica.", "questions": "[\"What chronic lung disease category did asthma and COPD belong to?\", \"Which other conditions were included besides asthma and COPD?\"]", "answers": "[\"Chronic lung disease\", \"Asthma and COPD\"]"}
{"id": "PubMed_9:840", "en": "Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.", "es": "Por último, para algunas afecciones médicas subyacentes, incluidos trastornos neurológicos, enfermedad hepática crónica, condición actual de fumador y embarazo, se informaron pocas complicaciones graves; por lo tanto, no es posible sacar conclusiones sobre el riesgo de COVID-19 grave entre personas de estos grupos.", "questions": "[\"What conditions and risk factors are mentioned?\", \"What types of outcomes were few for certain groups?\", \"What can't be concluded about the risk for severe COVID-19?\", \"What are the risk factors mentioned in the sentence?\"]", "answers": "[\"Neurologic disorders, chronic liver disease, being a current smoker, and pregnancy\", \"Severe outcomes\", \"Conclusions\", \"Neurologic disorders, chronic liver disease, being a current smoker, and pregnancy\"]"}
{"id": "PubMed_9:841", "en": "Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.", "es": "Las personas de Estados Unidos con afecciones médicas subyacentes aparentemente tienen un mayor riesgo de enfermarse más gravemente de COVID-19, lo que coincide con datos de otros países.", "questions": "[\"What appears to be at higher risk for more severe COVID-19?\", \"Which group of persons is mentioned in the sentence?\", \"What kind of conditions are described as appearing to be higher risk?\", \"Are there findings from other countries that are consistent with this statement?\", \"Is there mention of underlying health conditions being at higher risk for severe COVID-19?\"]", "answers": "[\"Persons in the United States\"], [\"Persons in the United States\"], [\"underlying health conditions\"], [\"consistent findings from other countries\"], [\"underlying health conditions\"])"}
{"id": "PubMed_9:842", "en": "Persons with underlying health conditions who have symptoms of COVID-19, including fever, cough, or shortness of breath, should immediately contact their health care provider.", "es": "Las personas con afecciones médicas subyacentes que tienen síntomas de COVID-19, como fiebre, tos o disnea, deben comunicarse de inmediato con su proveedor de atención médica.", "questions": "[\"What should persons with underlying health conditions do if they have symptoms of COVID-19?\", \"Which symptoms are mentioned as reasons to contact a health care provider?\", \"Who is advised to contact their health care provider if they have certain symptoms?\"]", "answers": "[\"immediately contact their health care provider\", \"fever, cough, or shortness of breath\", \"persons with underlying health conditions\"]"}
{"id": "PubMed_9:843", "en": "These persons should take steps to protect themselves from COVID-19, through washing their hands; cleaning and disinfecting high-touch surfaces; and social distancing, including staying at home, avoiding crowds, gatherings, and travel, and avoiding contact with persons who are ill.", "es": "Estas personas deberían tomar medidas para protegerse de la COVID-19, como lavarse las manos, limpiar y desinfectar superficies de mucho contacto, y mantener el distanciamiento físico, lo que incluye quedarse en casa; evitar las multitudes, las reuniones y los viajes, y evitar el contacto con personas que estén enfermas.", "questions": "[\"What steps should these persons take to protect themselves from COVID-19?\", \"What are some examples of steps to protect oneself from COVID-19?\", \"What does social distancing include according to the sentence?\", \"What are high-touch surfaces that need cleaning and disinfecting?\", \"What behaviors should be avoided to prevent the spread of COVID-19?\"]", "answers": "[\"washing their hands; cleaning and disinfecting high-touch surfaces; and social distancing\"], [\"washing their hands, cleaning and disinfecting high-touch surfaces, and social distancing, including staying at home, avoiding crowds, gatherings, and travel, and avoiding contact with persons who are ill\"], [\"staying at home, avoiding crowds, gatherings, and travel\"], [ \"high-touch surfaces\"], [\"travel, contact with persons who are ill, and gatherings\"])"}
{"id": "PubMed_9:844", "en": "Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.", "es": "Para quienes tienen afecciones médicas subyacentes, se recomienda mantener al menos un suministro de medicamentos para 30 días y un suministro de alimentos y otros artículos de necesidad para 2 semanas, y estar informado sobre los síntomas de la COVID-19.", "questions": "[\"What are recommended for those with underlying health conditions?\", \"What does maintaining a supply of include?\", \"How long should the supply of medication be?\", \"What else besides medication should be maintained in supply?\", \"What are some examples of necessities mentioned?\", \"What information is advised to have regarding COVID-19 symptoms?\"]", "answers": "[\"A 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms\"], [\"A 30-day supply of medication\"], [\"at least 30 days\"], [\"food and other necessities\"], [\"food and other necessities\"], [\"COVID-19 symptoms\"])"}
{"id": "PubMed_9:845", "en": "All persons should take steps to protect themselves from COVID-19 and to protect others.", "es": "Todas las personas deben tomar medidas para protegerse de la COVID-19 y proteger a los demás.", "questions": "[\"What steps should all persons take to protect themselves from COVID-19?\", \"What is the purpose of taking steps to protect others?\", \"What can be done to protect oneself from COVID-19?\", \"What is the goal of protecting others from COVID-19?\"]", "answers": "[\"Take steps to protect themselves\", \"Protect others\", \"Take steps to protect themselves\", \"Protect others\"]"}
{"id": "PubMed_9:846", "en": "All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.", "es": "Todas las personas que estén enfermas deben quedarse en casa, salvo que necesiten atención médica; no deben ir a trabajar y deben mantenerse alejadas de los demás.", "questions": "[\"What should ill persons do?\", \"What are the exceptions to staying home?\", \"What should ill persons avoid doing?\", \"What is the purpose of staying home when ill?\"]", "answers": "[\"Stay home, except to get medical care\", \"Going to work\", \"Staying away from others\", \"Avoiding spreading illness\"]"}
{"id": "PubMed_9:847", "en": "This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.", "es": "Esto es especialmente importante para aquellos que trabajan con personas que tienen afecciones subyacentes o que, por otro motivo, tienen un riesgo alto de tener complicaciones graves a causa de la COVID-19.", "questions": "[\"What is especially important?\", \"For whom is this especially important?\", \"What does this relate to?\", \"What kind of persons are at high risk for severe outcomes from COVID-19?\", \"What does 'underlying conditions' refer to?\"]", "answers": "[\"This\"], [\"those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19\"], [\"COVID-19\"], [\"persons with underlying conditions\"], [\"underlying conditions\"]"}
{"id": "PubMed_9:848", "en": "Community mitigation strategies, which aim to slow the spread of COVID-19, are important to protect all persons from COVID-19, especially persons with underlying health conditions and other persons at risk for severe COVID-19–associated disease (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).", "es": "Las estrategias de mitigación comunitaria, cuyo objetivo es frenar la propagación de la COVID-19, son importantes para proteger a todas las personas de la COVID-19, en especial a las personas con afecciones médicas subyacentes y otras personas en riesgo de enfermedad grave asociada a la COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).", "questions": "[\"What are community mitigation strategies aimed at?\", \"What is the main purpose of community mitigation strategies?\", \"Who are community mitigation strategies important to protect?\", \"What groups are specifically mentioned as being at risk?\", \"What does the sentence link community mitigation strategies to?\"]", "answers": "[\"slow the spread of COVID-19\"], [\"protect all persons from COVID-19\"], [\"all persons\"], [\"persons with underlying health conditions and other persons at risk for severe COVID-19–associated disease\"], [\"to\"])"}
{"id": "PubMed_9:849", "en": "What is already known about this topic?", "es": "¿Qué ya se sabe sobre este tema?", "questions": "[\"What is already known about this topic?\"]", "answers": "[\"What is already known about this topic?\"]"}
{"id": "PubMed_9:850", "en": "Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "es": "Informes publicados de China e Italia sugieren que los factores de riesgo para enfermarse gravemente de COVID-19 incluyen las afecciones médicas subyacentes, pero aún no se han publicado datos que describan las afecciones médicas subyacentes en pacientes estadounidenses con COVID-19.", "questions": "[\"What are risk factors for severe COVID-19 disease according to published reports?\", \"What type of data has not yet been reported?\", \"What health conditions are mentioned as risk factors?\", \"Where were the published reports from China and Italy based on?\"]", "answers": "[\"underlying health conditions\", \"data describing underlying health conditions among U.S. COVID-19 patients\", \"underlying health conditions\", \"China and Italy\"]"}
{"id": "PubMed_9:851", "en": "What is added by this report?", "es": "¿Qué agrega este informe?", "questions": "[\"What is added by this report?\", \"What information does this report provide?\", \"What new details are included in this report?\"]", "answers": "[\"New details about the subject matter\", \"Information about the subject matter\", \"New details\"]"}
{"id": "PubMed_9:852", "en": "Based on preliminary U.S. data, persons with underlying health conditions such as diabetes mellitus, chronic lung disease, and cardiovascular disease, appear to be at higher risk for severe COVID-19–associated disease than persons without these conditions.", "es": "Sobre la base de datos preliminares de EE. UU., las personas con afecciones médicas subyacentes, como diabetes mellitus, enfermedad pulmonar crónica y enfermedad cardiovascular, aparentemente tienen un riesgo mayor de enfermarse gravemente a causa de la COVID-19 que las personas que no tienen estas afecciones.", "questions": "[\"What underlying health conditions are mentioned?\", \"What type of data is used to make this determination?\", \"Who appears to be at higher risk?\", \"What is the risk associated with these conditions?\", \"What is the disease being discussed?\"]", "answers": "[\"diabetes mellitus, chronic lung disease, and cardiovascular disease\"], [\"preliminary U.S. data\"], [\"persons with underlying health conditions\"], [\"higher risk for severe COVID-19-associated disease\"], [\"COVID-19\"])"}
